ConductScience.org, home

Paper41449309

Multiple system atrophy: advances in pathogenesis and emerging therapeutic strategies.

Chen Z and 2 others. J Neurol, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Multiple system atrophy: advances in pathogenesis and emerging therapeutic strategies. Papers, record 41449309. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41449309

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multiple system atrophy: advances in pathogenesis and emerging therapeutic strategies.
PubMed
Journal
J Neurol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-11-05
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen ZZhiqing
2Mei LLin
3Huang YYuehttps://orcid.org/0000-0001-6051-2241

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Multiple System AtrophyMajor topic
Humans
alpha-Synuclein
Animals

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2022SKLID306State Key Laboratory of Infectious Disease Prevention and ControlPubMed
T2488101National Natural Science Foundation of ChinaPubMed
82071417National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References178

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125498732Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial.Lancet Neurol2015https://conductscience.org/library/papers/25498732PubMed
239405585Multiple System Atrophy: Pathology, Pathogenesis, and Path Forward.Annu Rev Pathol2025https://conductscience.org/library/papers/39405585PubMed
332882100A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy.Mov Disord2020https://conductscience.org/library/papers/32882100PubMed
436097244Clinical and Genetic Features of Multiplex Families with Multiple System Atrophy and Parkinson's Disease.Cerebellum2024https://conductscience.org/library/papers/36097244PubMed
523116538Treatment of multiple system atrophy using intravenous immunoglobulin.BMC Neurol2012https://conductscience.org/library/papers/23116538PubMed
614748560Microglial activation parallels system degeneration in multiple system atrophy.J Neuropathol Exp Neurol2004https://conductscience.org/library/papers/14748560PubMed
731751571FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models.Exp Neurol2020https://conductscience.org/library/papers/31751571PubMed
840619658The Fragile Balance: Autophagy's Role in Neurodegenerative Disease Progression.Curr Neuropharmacol2026https://conductscience.org/library/papers/40619658PubMed
935210396Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy.Transl Psychiatry2022https://conductscience.org/library/papers/35210396PubMed
1032576494Cerebrospinal fluid myelin basic protein is elevated in multiple system atrophy.Parkinsonism Relat Disord2020https://conductscience.org/library/papers/32576494PubMed
1135903017Neurofilament light levels predict clinical progression and death in multiple system atrophy.Brain2022https://conductscience.org/library/papers/35903017PubMed
1227629089A genome-wide association study in multiple system atrophy.Neurology2016https://conductscience.org/library/papers/27629089PubMed
1331649208Differentiation of Human Mesenchymal Stem Cells towards Neuronal Lineage: Clinical Trials in Nervous System Disorders.Biomol Ther (Seoul)2020https://conductscience.org/library/papers/31649208PubMed
1431434803Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies.JCI Insight2019https://conductscience.org/library/papers/31434803PubMed
1537488838Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings.Neural Regen Res2024https://conductscience.org/library/papers/37488838PubMed
1633941284Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophy.Acta Neuropathol Commun2021https://conductscience.org/library/papers/33941284PubMed
1728659169The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease.Acta Neuropathol Commun2017https://conductscience.org/library/papers/28659169PubMed
1836922526Head-to-head comparison of 6 plasma biomarkers in early multiple system atrophy.NPJ Parkinsons Dis2023https://conductscience.org/library/papers/36922526PubMed
1928053341Gut-brain axis in 2016: Brain-gut-microbiota axis - mood, metabolism and behaviour.Nat Rev Gastroenterol Hepatol2017https://conductscience.org/library/papers/28053341PubMed
2024907278How epigallocatechin gallate can inhibit α-synuclein oligomer toxicity in vitro.J Biol Chem2014https://conductscience.org/library/papers/24907278PubMed

See all 178 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42589103Natural Product-Derived Carbon Dots in Neurodegenerative Diseases: Advances in Blood-Brain-Barrier-Related Delivery, Neuroprotection, and Theranostics.Biology (Basel)2026https://conductscience.org/library/papers/42589103PubMed
42463685Plasma ceramide ratios define metabolic-inflammatory associations with cognitive impairment in Parkinson's disease.NPJ Parkinsons Dis2026https://conductscience.org/library/papers/42463685PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SNCA6622PubTator's text mininghttps://conductscience.org/library/genes/6622

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41449309

GET https://conductscience.org/api/papers/v1/41449309/references?page=2